Zhewitra Oral Jelly
$ 61,00 – $ 110,00Price range: $ 61,00 through $ 110,00
Zithromax
$ 40,00 – $ 865,00Price range: $ 40,00 through $ 865,00
Zhewitra Soft
$ 54,00 – $ 210,00Price range: $ 54,00 through $ 210,00
Zhewitra Soft is a highly effective medication specifically formulated to treat erectile dysfunction and enhance male sexual performance. These chewable tablets contain Vardenafil, a powerful ingredient that improves blood flow to ensure a firm and lasting erection. The soft formulation allows for quicker absorption compared to standard pills, leading to a faster onset of action when it is needed most. By supporting natural physiological responses to stimulation, the product helps men regain their confidence and enjoy a more fulfilling intimate life. Each dose provides reliable results, ensuring you are ready for spontaneous moments with improved stamina and control.
Active substance: Vardenafil
SKU:
Zhewitra Soft
Categories: Erectile Dysfunction, Men's Health
Delivery: 5–21 days (depending on the shipping method)
Extra 10% discount with coupon: IT4K6SVM
Each dosage option has its own packaging choices.
Description
Zhewitra Soft belongs to a group of medicines called phosphodiesterase type 5 (PDE5) inhibitors, containing vardenafil as its active pharmaceutical ingredient. It is prescribed for the treatment of erectile dysfunction (ED) in adult males, helping to facilitate an erectile response during sexual stimulation. In accordance with applicable federal and state regulations in the United States, this medication is dispensed by prescription only following evaluation by a qualified healthcare provider.
Formulated as a soft chewable tablet, Zhewitra Soft offers an alternative oral administration route for individuals who prefer not to swallow conventional film-coated tablets. Proper medical assessment is required prior to initiating therapy to assess underlying cardiovascular health, screen for potentially dangerous drug interactions, and determine an appropriate dosage schedule.
| Parameter | Specification |
|---|---|
| Active Ingredient | Vardenafil |
| Therapeutic Class | Phosphodiesterase Type 5 (PDE5) Inhibitor |
| Dosage Form | Soft Chewable Tablet |
| Route of Administration | Oral |
| Primary Indication | Erectile Dysfunction (ED) |
| Prescription Status | Prescription (Rx) required in the United States |
| Storage Requirements | Controlled room temperature (68°F to 77°F / 20°C to 25°C) |
Clinical Profile and Pharmacological Action
Main Uses
Vardenafil is indicated primarily for the management of erectile dysfunction, a medical condition characterized by the persistent inability to attain or sustain a penile erection sufficient for satisfactory sexual performance. The drug specifically targets the physiological mechanisms of vascular relaxation within the erectile tissue. It does not act as an aphrodisiac, nor does it increase sexual desire or cure the underlying systemic causes of erectile dysfunction. Off-label uses of PDE5 inhibitors–such as off-label protocols for secondary vascular symptoms or Raynaud’s phenomenon–are strictly non-standard applications that require distinct clinical oversight and are not approved standard indications for this specific formulation.
How the Drug Works
The mechanism of action involves the selective inhibition of cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase type 5 (PDE5). During sexual arousal, local nitric oxide is released from nerve terminals and endothelial cells within the corpus cavernosum of the penis. Nitric oxide activates guanylate cyclase, leading to increased synthesis of cGMP. Elevated cGMP levels induce smooth muscle relaxation in the arterial walls and trabecular tissue, promoting increased arterial inflow into the penis. PDE5 is the primary enzyme responsible for breaking down cGMP. By inhibiting PDE5, vardenafil preserves cGMP levels, thereby enhancing the natural physiological erectile response during sexual stimulation.
What Happens in the Body
Following oral administration, vardenafil is absorbed relatively rapidly. Peak plasma concentrations are typically achieved within 30 to 120 minutes in a fasting state. High-fat meals can delay the rate of absorption and reduce peak plasma concentrations. The absolute bioavailability of vardenafil is approximately 15% due to extensive first-pass hepatic metabolism. Vardenafil is approximately 95% bound to plasma proteins. Metabolism occurs predominantly via the liver enzyme cytochrome P450 (CYP) 3A4, with minor contributions from CYP3A5 and CYP2C isoforms. The mean terminal elimination half-life is approximately 4 to 5 hours. Excretion occurs mainly as metabolites via the feces (approximately 79%), with a smaller portion excreted through the urine (approximately 13%).
Administration, Safety, and Usage Guidelines
Dosing Schedule and Administration
Zhewitra Soft is intended for oral administration as a chewable tablet. Clinical dosing guidelines for vardenafil generally recommend a starting dose of 10 mg taken approximately 25 to 60 minutes prior to anticipated sexual activity. The dosage may be adjusted by a prescribing physician within a range of 5 mg to 20 mg based on individual efficacy and tolerability. The maximum recommended dosing frequency is once per 24-hour period. Chewable tablets should be chewed thoroughly before swallowing. Dosage adjustments or lower starting doses may be warranted for geriatric patients, individuals with moderate hepatic impairment, or those receiving concurrent mild to moderate CYP3A4 inhibitors.
First Days of Treatment
When starting therapy with Zhewitra Soft, patients should understand that the drug requires physiological sexual stimulation to function. Early doses provide an opportunity for the patient and healthcare provider to gauge response and observe for potential transient side effects such as mild flushing or headache. If an initial dose does not achieve adequate clinical response, patients should not independently increase the dose. Prescribers frequently advise attempting the prescribed dose on several separate occasions before assessing overall efficacy or adjusting the therapeutic regimen.
Signs of Improvement
Evaluating clinical progress involves observing the ability to achieve and maintain an erection adequate for sexual intercourse following appropriate stimulation. Therapeutic efficacy is marked by improved erectile quality, consistency, and duration during activity. If a patient continues to experience inadequate erectile function despite using the medication as instructed across multiple attempts, a physician should be consulted to evaluate potential dosage adjustment, treatment adherence factors, or underlying secondary medical conditions.
What to Avoid While Taking It
Patients taking Zhewitra Soft should avoid consuming grapefruit or grapefruit juice. Grapefruit components inhibit CYP3A4 enzymes, which can significantly raise plasma levels of vardenafil and increase the frequency or severity of side effects. Alcohol consumption should be strictly limited, as heavy alcohol intake can independently impair erectile performance and potentiate systemic vasodilatory effects, increasing the risk of orthostatic hypotension, dizziness, and headache. Heavy or excessively high-fat meals taken immediately before administration should also be avoided to prevent delayed clinical onset.
Compatibility with Other Medicines
Vardenafil is strictly contraindicated in patients taking any form of organic nitrates (e.g., nitroglycerin, isosorbide mononitrate, isosorbide dinitrate) or nitric oxide donors (such as amyl nitrite). Co-administration can cause a sudden, severe, and potentially life-threatening drop in blood pressure. Caution is required when combining vardenafil with alpha-blockers (e.g., tamsulosin, doxazosin); concurrent use can lead to symptomatic hypotension. Potent CYP3A4 inhibitors (such as ketoconazole, itraconazole, ritonavir, and clarithromycin) markedly increase vardenafil concentrations, requiring strict dose restrictions or avoidance. Concurrent use with other PDE5 inhibitors or alternative ED therapies is not recommended.
Important Precautions
Cardiovascular status must be evaluated by a healthcare provider prior to initiating treatment, as sexual activity carries a degree of cardiac risk in patients with preexisting heart conditions. Vardenafil is generally not recommended for individuals with severe cardiovascular instability, recent myocardial infarction or stroke (within the last 6 months), resting hypotension, severe uncontrolled hypertension, or unstable angina. Caution is advised in patients with congenital QT prolongation or those taking Class IA or Class III antiarrhythmic medications due to potential QTc interval prolongation. Special populations, including elderly patients and those with hepatic or renal impairment, require tailored medical supervision.
Adverse Reactions
The most commonly reported side effects associated with vardenafil include headache, facial flushing, nasal congestion, dyspepsia, and dizziness. Less frequent adverse events include back pain, musculoskeletal stiffness, and visual disturbances such as transient color alteration or increased light sensitivity. Severe but rare adverse reactions require immediate medical care. These include priapism (a prolonged erection lasting longer than 4 hours), which can cause permanent structural damage to penile tissue if untreated. Sudden decrease or loss of vision (associated with non-arteritic anterior ischemic optic neuropathy, NAION) and sudden decrease or hearing loss have been reported rarely with PDE5 inhibitors; occurrence of these symptoms necessitates immediate drug discontinuation and emergency evaluation.
Storage and Expiration
Zhewitra Soft should be stored at controlled room temperature, ideally between 68°F and 77°F (20°C to 25°C), with permitted excursions between 59°F and 86°F (15°C to 30°C) under United States Pharmacopeia standards. Keep the tablets in their original packaging to protect the product from excessive moisture and light. Store safely out of the reach of children and domestic animals. Expirations dates are printed on the blister packaging; medications should not be used past the indicated expiration date.
Common Questions
How does the chewable formulation of Zhewitra Soft differ in administration from traditional film-coated tablets?
The soft chewable form is designed to be thoroughly chewed before swallowing, providing an alternative for patients who have difficulty swallowing whole conventional tablets. However, the active ingredient (vardenafil) and the fundamental requirement for hepatic metabolism remain identical to conventional oral forms.
What immediate actions must be taken if an erection lasts longer than 4 hours?
An erection lasting longer than 4 hours is a medical emergency known as priapism. Immediate emergency room evaluation is necessary. Delaying treatment can cause irreversible damage to erectile tissue and permanent loss of potency.
Is it safe to drive or operate machinery after taking Zhewitra Soft?
Patients should assess their individual response to the medication before driving or operating machinery. Side effects such as dizziness or transient visual disturbances can occur; if these symptoms are experienced, activities requiring sharp alertness should be avoided.
Can Zhewitra Soft be taken on a daily scheduled basis?
Vardenafil is generally prescribed for use on an as-needed basis prior to anticipated sexual activity, with a maximum frequency of once per day. It is not intended for continuous daily administration unless explicitly instructed by a prescribing physician.
How do moderate liver or kidney impairments alter the usage of this drug?
Because vardenafil is cleared primarily by hepatic metabolism, moderate hepatic impairment reduces clearance and increases systemic exposure. In such cases, or in severe renal impairment, physicians typically recommend a lower starting dose (such as 5 mg) and careful clinical monitoring.
In accordance with FDA requirements, prescription medications require appropriate medical consultation and evaluation.
This material is educational. Only a licensed prescriber can determine whether a medication is appropriate for you.
Additional information
| Dosage |
20 mg |
|---|---|
| Package |
20 pills ,30 pills ,90 pills ,120 pills ,180 pills ,270 pills |
| Ενεργός Ουσία |
Related products
Abhigra
$ 69,00 – $ 173,00Price range: $ 69,00 through $ 173,00
Active substance: Sildenafil
More Details
This product has multiple variants. The options may be chosen on the product page
Avana
$ 112,00 – $ 419,00Price range: $ 112,00 through $ 419,00
Active substance: Avanafil
More Details
This product has multiple variants. The options may be chosen on the product page
Caverta
$ 135,00 – $ 248,00Price range: $ 135,00 through $ 248,00
Active substance: Sildenafil
More Details
This product has multiple variants. The options may be chosen on the product page
Cialis
$ 40,00 – $ 470,00Price range: $ 40,00 through $ 470,00
Active substance: Tadalafil
More Details
This product has multiple variants. The options may be chosen on the product page
Cialis Daily
$ 43,00 – $ 285,00Price range: $ 43,00 through $ 285,00
Active substance: Tadalafil
More Details
This product has multiple variants. The options may be chosen on the product page
Cialis Extra Dosage
$ 50,00 – $ 650,00Price range: $ 50,00 through $ 650,00
Active substance: Tadalafil
More Details
This product has multiple variants. The options may be chosen on the product page
Cialis Professional
$ 45,00 – $ 490,00Price range: $ 45,00 through $ 490,00
Active substance: Tadalafil
More Details
This product has multiple variants. The options may be chosen on the product page
Erectafil
$ 60,00 – $ 466,00Price range: $ 60,00 through $ 466,00
Active substance: Tadalafil
More Details
This product has multiple variants. The options may be chosen on the product page
